2' O (1H TETRAZOL 5 YL)ETHYLADENOSINE;
2' O [(1 N CYANOETHYLTETRAZOL 5 YL)ETHYL] 6 N PHENOXYACETYL 3',5' O (1,1,3,3 TETRAISOPROPYLDISILOXANE 1,3 DIYL)ADENOSINE;
2' O [(1 N METHYLTETRAZOL 5 YL)ETHYL] 6 N PHENOXYACETYL 3',5' O (1,1,3,3 TETRAISOPROPYLDISILOXANE 1,3 DIYL)ADENOSINE;
2' O [(1 N METHYLTETRAZOL 5 YL)ETHYL] 6 N PHENOXYCAETYLADENOSINE;
2' O [(2 N CYANOETHYLTETAZOL 5 YL)ETHYL] 5' O (4,4' DIMETHOXYTRITYL) 6 N PHENOXYACETYLADENOSINE 3' (2 CYANOETHYL N,N DIISOPROPYLPHOSPHORAMIDITE;
2' O [(2 N CYANOETHYLTETRAZOL 5 YL)] 5' O (4,4' DIMETHOXYTRITYL) 6 N PHENOXYACETYLADENOSINE;
2' O [(2 N CYANOETHYLTETRAZOL 5 YL)ETHYL] 6 N PHENOXYACETYLADENOSINE;
2' O [2 (TETRAZOL 5 YL)ETHYL]ADENOSINE;
2' O CYANOETHYLADENOSINE;
3',5' O (1,1,3,3 TETRAISOPROPYLDISILOXANE 1,3 DIYL) 2' O [2 (TETRAZOL 5 YL)ETHYL]ADENOSINE;
5' O (4,4' DIMETHOXYTRITYL) 2' O [(1 N METHYLTETRAZOL 5 YL)ETHYL] 6 N PHENOXYACETYLADENOSINE;
5' O (4,4' DIMETHOXYTRITYL) 2' O [(1 N METHYLTETRAZOL 5 YL)ETHYL] 6 N PHENOXYACETYLADENOSINE 3' 2 CYANOETHYL N,N DIISOPROPYLPHOSPHORAMIDITE;
6 N PHENOXYACETYL 3',5' O (1,1,3,3 TETRAISOPROPYLDISILOXANE 1,3 DIYL) 2' O [2 TETRAZOL 5 YL)ETHYL]ADENOSINE;
ADENOSINE DERIVATIVE;
OLIGODEOXYNUCLEOTIDE DERIVATIVE;
OLIGONUCLEOTIDE;
TETRAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CHEMICAL REACTION;
CHEMICAL STRUCTURE;
HETERONUCLEAR MULTIPLE BOND CORRELATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HYBRIDIZATION;
MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;
PHOSPHORUS NUCLEAR MAGNETIC RESONANCE;
PHYSICAL CHEMISTRY;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
PROTON TRANSPORT;
SOLID PHASE SYNTHESIS;
STEREOSPECIFICITY;
THERMODYNAMICS;
Qu Z., Zhao H., Xi-Sen Wang X., Li Y., Song Y., Liu Y., Ye Q., Xiong R., Brendan F., Abrahams B.F., Xue Z., and You X. Inorg. Chem. 42 (2003) 7710-7712